EP0062, ORSERDU 86 mg film-coated tablets, ORSERDU 345 mg film-coated tablets
EP0062-101
Phase 2 small_molecule active
Quick answer
EP0062, ORSERDU 86 mg film-coated tablets, ORSERDU 345 mg film-coated tablets for Breast Cancer is a Phase 2 program (small_molecule) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lacuna Pharma Pty Ltd
- Indication
- Breast Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active